|
HMBOX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.88098450546204E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.94479987669638E-11 |
| Normal-vs-Stage2 |
6.06609984465933E-10 |
| Normal-vs-Stage3 |
1.8446355554147E-12 |
| Normal-vs-Stage4 |
1.93400850889702E-12 |
| Stage1-vs-Stage2 |
9.651200E-01 |
| Stage1-vs-Stage3 |
2.571800E-02 |
| Stage1-vs-Stage4 |
3.358400E-02 |
| Stage2-vs-Stage3 |
1.153620E-01 |
| Stage2-vs-Stage4 |
1.141600E-01 |
| Stage3-vs-Stage4 |
8.014400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.64528415733412E-12 |
| Normal-vs-AfricanAmerican |
6.40440001031806E-09 |
| Normal-vs-Asian |
6.64568400310372E-12 |
| Caucasian-vs-AfricanAmerican |
8.875600E-01 |
| Caucasian-vs-Asian |
4.949600E-01 |
| AfricanAmerican-vs-Asian |
5.321800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.7928327973068E-13 |
| Normal-vs-Female |
1.05589981203025E-11 |
| Male-vs-Female |
1.124020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.44470032895583E-11 |
| Normal-vs-Age(41-60Yrs) |
2.51343390544889E-12 |
| Normal-vs-Age(61-80Yrs) |
3.85214082854191E-12 |
| Normal-vs-Age(81-100Yrs) |
4.640300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.048000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.196200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.046600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.972200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.911600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.261600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.944100E-03 |
| Classical-VS-Follicular |
9.960200E-01 |
| Classical-VS-Other |
2.237800E-01 |
| Classical-VS-Normal |
2.7427948801062E-11 |
| Tall-VS-Follicular |
3.786300E-02 |
| Tall-VS-Other |
9.026000E-01 |
| Tall-VS-Normal |
1.76014758324072E-12 |
| Follicular-VS-Other |
3.825000E-01 |
| Follicular-VS-Normal |
2.2118973319607E-11 |
| Other-VS-Normal |
1.00300000005493E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.11346520681855E-12 |
| Normal-vs-N1 |
4.65449900843851E-12 |
| N0-vs-N1 |
4.930000E-01 |
|
|
